Lord, Abbett & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-459,588
Closed -$8.81M 579
2024
Q4
$8.81M Buy
459,588
+67,630
+17% +$1.3M 0.03% 399
2024
Q3
$8.92M Buy
+391,958
New +$8.92M 0.03% 413